UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 458

Sortiert nach

Epidermal growth factor receptor inhibition in mutation-positive non-small-cell lung cancer: is afatinib better or simply newer?

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3303-3306

Langer, Corey J

2013

Link zum Volltext

Verfügbarkeit prüfen

Exploring biomarkers in head and neck cancer

Cancer, 2012-08, Vol.118 (16), p.3882-3892

Langer, Corey J.

2012

Link zum Volltext

Verfügbarkeit prüfen

The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-12, Vol.28 (36), p.5311-5320

2010

Link zum Volltext

Verfügbarkeit prüfen

Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial

Journal of thoracic oncology, 2020-03, Vol.15 (3), p.404-415

2020

Link zum Volltext

Verfügbarkeit prüfen

Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety”

Lung cancer (Amsterdam, Netherlands), 2016-10, Vol.100, p.110-113

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

Journal of clinical oncology, 2009-05, Vol.27 (15), p.2530-2535

2009

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.273-281

2018

Link zum Volltext

Verfügbarkeit prüfen

Current Management of Brain Metastases, With a Focus on Systemic Options

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6207-6219

2005

Link zum Volltext

Verfügbarkeit prüfen

A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma

PloS one, 2022-09, Vol.17 (9), p.e0275187-e0275187

2022

Link zum Volltext

Verfügbarkeit prüfen

National Cancer Database report on cancer of the head and neck: 10-Year update

Head & neck, 2009-06, Vol.31 (6), p.748-758

2009

Link zum Volltext

Verfügbarkeit prüfen

Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5255-5261

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2060-2065

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic Features of Advanced Squamous NSCLC

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1411-1422

2016

Link zum Volltext

Verfügbarkeit prüfen

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

Journal of clinical oncology, 2008-01, Vol.26 (1), p.60-65

2008

Link zum Volltext

Verfügbarkeit prüfen

Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival

The Laryngoscope, 2006-09, Vol.116 (S111), p.1-13

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911

Journal of clinical oncology, 2007-10, Vol.25 (30), p.4800-4805

2007

Link zum Volltext

Verfügbarkeit prüfen

Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma

Journal for immunotherapy of cancer, 2020-10, Vol.8 (2), p.e000974

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2004-06, Vol.22 (11), p.2184-2191

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-05, Vol.27 (15), p.2516-2522

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic

BMC cancer, 2021-10, Vol.21 (1), p.1-1094, Article 1094

2021

Link zum Volltext

Verfügbarkeit prüfen

Penetration of Recommended Procedures for Lung Cancer Staging and Management in the United States Over 10 Years: A Quality Research in Radiation Oncology Survey

International journal of radiation oncology, biology, physics, 2013-03, Vol.85 (4), p.1082-1089

2013

Link zum Volltext

Verfügbarkeit prüfen

Management of Lung Cancer During the COVID-19 Pandemic

JCO oncology practice, 2020-09, Vol.16 (9), p.579-586

2020

Link zum Volltext

Verfügbarkeit prüfen

Emerging immunotherapies in the treatment of non-small cell lung cancer (NSCLC): the role of immune checkpoint inhibitors

American journal of clinical oncology, 2015-08, Vol.38 (4), p.422-430

Langer, Corey J

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 458

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(431)
Mit Volltextzugriff
(432)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(235)
Life Sciences & Biomedicine
(230)
Humans
(228)
Oncology
(206)
Female
(131)
Male
(130)
Middle Aged
(119)
Aged
(118)
Lung Neoplasms - Drug Therapy
(108)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(97)
Adult
(81)
Biological And Medical Sciences
(78)
Medical Sciences
(78)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(76)
Lung Neoplasms - Pathology
(74)
Chemotherapy
(63)
Carcinoma, Non-Small-Cell Lung - Pathology
(60)
Treatment Outcome
(53)
Hematology, Oncology And Palliative Medicine
(51)
Aged, 80 And Over
(47)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

Epidermal growth factor receptor inhibition in mutation-positive non-small-cell lung cancer: is afatinib better or simply newer?

Exploring biomarkers in head and neck cancer

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer

Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial

Scan-associated distress in lung cancer: Quantifying the impact of “scanxiety”

Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study

Current Management of Brain Metastases, With a Focus on Systemic Options

A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma

National Cancer Database report on cancer of the head and neck: 10-Year update

Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases

Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma

Clinicopathologic Features of Advanced Squamous NSCLC

Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599

Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival

Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911

Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer

Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic

Penetration of Recommended Procedures for Lung Cancer Staging and Management in the United States Over 10 Years: A Quality Research in Radiation Oncology Survey

Management of Lung Cancer During the COVID-19 Pandemic

Emerging immunotherapies in the treatment of non-small cell lung cancer (NSCLC): the role of immune checkpoint inhibitors

Suchergebnisse filtern